Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out

Scroll down and select country
MEBO TMAU TESTING CURRENTLY SUSPENDED INDEFINITELY

MEBO - UBIOME study 2018

'PRESS RELEASE'

NCT03582826
ClinicalTrials.gov

MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production
& PATM

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person

NO LONGER RECRUITING

Participation info : LINK English

MEBO Map Testing & Meetups


Full details : https://goo.gl/TMw8xu
want listed ? contact info@meboresearch.org

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts

MEBO TMAU Videos

Petitions

TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study
NCT02683876

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned


Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
EURORDIS and
NORD Member Organization
See RareConnect

Popular Posts (last 30 days)

Upcoming get-togethers


Let us know if you want a meetup listed

Subscribe to Blog

Enter your email address:

Delivered by FeedBurner

You will be sent a verification email

Subscribe in a reader

Blog Archive

MEBO Research Clinical Trials

Click here to read details of the MEBO Clinical Trials
NCT03582826 - Ongoing not recruiting
Microbial Basis of Systemic Malodor and PATM Conditions (PATM)
United States 2018 - ongoing

NCT02683876 - Completed
Exploratory Study of Relationships Between Malodor and Urine Metabolomics
Canada and United States 2016 - ongoing

NCT03451994 - Completed
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
United Kingdom and United States 2013 - ongoing

NCT02692495 - Completed
Evaluation of Potential Screening Tools for Metabolic Body Odor and Halitosis
United Kingdom 2009 - 2012

Monday, October 26, 2009

Expert overseeing MEBO Research Studies

we are most grateful to Dr. Irene Gabashvili, PhD, for overseeing MEBO Research's exploratory trials. She brings with her years of experience in biomedical industry and academia. Dr. Irene is the founder of Aurametrix, which she continues to develop as she works very closely with the MEBO community to address our needs.  She heads the MEBO directorship as we explore new groundbreaking research possibilities in an effort to develop accurate diagnosis, treatment and a cure to the various types of body and breath odor conditions.

Throughout her career, Dr. Gabashvili has been interested in the molecular, cellular, and physiological mechanisms of health and disease. She developed models and data analysis approaches and experimentally studied physics of microbial infection, chemistry of light and radiation effects on living matter, plant enzymes, structural basis of antibiotic resistance, human pathologies dependent on variation in mitochondrial genes, development of sensory apparatus and aging, and inheritance and environmental factors contributing to the development of diseases.

Dr. Gabashvili was overseeing exploratory trials and data mining studies in the past, working with medical doctors and supervising MD students. For example, she studied analysis of blood biomarkers to determine patterns of longevity at the Center of Genetic Ecology. She worked in microbiology, molecular biology, biochemistry and biophysics labs and was utilizing state-of-the-art techniques and instrumentation to characterize macro- and micro-molecules causing or protecting from disease. She continues to collaborate with experimental labs, in particular employing novel chromatographic and mass spectrometry approaches to identify disease biomarkers.

Dr. Gabashvili has developed software tools and IT infrastructure to support research and clinical processes. She worked with and for Hewlett Packard, Merck, Pfizer, Johnson & Johnson, Novartis, etc. Her academic partnerships include renowned scientists and clinicians from Stanford and Harvard Universities.

Dr. Gabashvili demonstrated a concerted interest in applying her wealth of knowledge to MEBO's research aims for the betterment of our community. She is especially interested in clinical nutrition and the complex relationship between the human immune system with trillions of microbes populating human beings. You can contact her directly by e-mailing to Irene at Aurametrix.com.


Irene Gabashvili, PhD
Scientific Director, MEBO Research
Founder of Aurametrix
irene@aurametrix.com & irene.gabashvili@meboresearch.org


See Slideshow presentation "Microbes and Us"
Alphabetical List of Pathogenic Bacteria

María

María de la Torre
Founder and Executive Director

A Public Charity
maria.delatorre@meboresearch.org
www.meboresearch.org
www.mebo.com.br (MEBO Brasil)
diretoria@mebo.com.br
The MEBO Blog (English)
El Blog de MEBO (español) 
NORD Member Organization
EURORDIS Member Organisation 



SUPPORT THE MEBO MISSION: Click Amazon button at right sidebar of this blog when shopping online
at no extra cost to you.
MEBO gets small commission from Amazon.


Please use your credit card to make your donation to MEBO.


Subscribe for latest posts : Enter your email address:

Delivered by FeedBurner


A EURORDIS and NORD Member Organization

0 comments:

Post a Comment